Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.
about
Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT)Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature ReviewCurrent status of transarterial radioembolizationTransarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular CarcinomaSide effects of yttrium-90 radioembolizationTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsThe role of interventional radiology in the management of hepatocellular carcinomaRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesSelective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver MalignanciesManagement strategies for hepatocellular carcinoma: old certainties and new realities.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization.Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.Radioembolization of hepatic tumorsDirect in vivo injection of 131I-GMS and its distribution and excretion in rabbitYttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver.Radioembolization of yttrium-90 microspheres for hepatic malignancy.Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinomaTransarterial therapies for hepatocellular carcinoma.Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes.Research reporting standards for radioembolization of hepatic malignancies.Presentation and outcomes of hepatocellular carcinoma patients at a western centre.Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization.The optimal selection of radiotherapy treatment for hepatocellular carcinomaPET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyFactors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignanciesEfficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumorsPET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor ResponseRadioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical reviewAdvances in experimental and translational research in the treatment of hepatocellular carcinomaEvidence-based diagnosis and locoregional therapy for hepatocellular carcinoma.Nonsurgical treatment for localized hepatocellular carcinoma.Liver transplantation after radioembolization in a patient with unresectable HCC.YCl3 Promotes Neuronal Cell Death by Inducing Apoptotic Pathways in Rats.Radiotherapeutic strategies in the management of hepatocellular carcinoma.
P2860
Q25257869-02C761F0-25E6-4612-B996-BB01768D68D0Q26743603-C852E28A-0639-4213-BCC3-58DDFA42D69FQ26744307-4436ACB0-3EB3-494D-9F05-B036BE6A905EQ26753089-B5B24CCB-DD3A-4907-A6D6-87780392675CQ26821887-F6E2FE8E-DBF1-45F4-827E-52617B2D9D4CQ26852174-9936C76D-60F1-46F6-BFF0-48ADA75A97EBQ26996805-6348F1C9-1BE8-49CA-9EA8-73A763919619Q27023616-4A1E44EF-EDAE-4720-B391-209F36F9CB48Q28071594-DBF87A4C-A080-4086-A841-90EC2202CBDBQ30252143-E181F552-6605-47B2-B417-FC8EDF075F82Q30468280-4CD0125A-BBEE-439E-BA34-5A838D01CAFBQ33410714-65FAC207-5CD8-459E-B790-A5628667C58CQ33691454-98244EA6-4DF7-4B09-A8B2-8286D0992CF3Q33820777-F547311C-169C-40DD-8457-8CA9F84ED04BQ33830713-2B41D614-96D7-4953-95ED-02A988C09F5CQ34563356-A491EDCB-61B9-4090-9564-EFA50722C658Q34563515-3EDCE988-6140-47E4-8715-F4895BA0DBC9Q34618735-0FD4455A-EB8E-4B6D-8CF5-A114D734056DQ34628257-60310A5A-B0DD-457D-955F-64B2FF8B4E68Q34991390-B039B037-C6FF-4211-B676-7B741F21D4A5Q35094057-3405AE1A-4832-4FBF-87DF-9C1972FA140DQ35111887-686552B2-0B2A-4B49-9CC6-56AEDC8166E5Q35535968-05872A9E-EBAC-4E63-AC09-A637E02D80F4Q35658025-9F0C6B21-0DDE-4B55-B249-D7AE49EF0333Q35721324-E78B62CD-6E99-41C6-803C-5253B73774C1Q35888586-2E7E1814-3AF3-4724-8CD9-644491683F07Q35931183-F3861423-18A0-414A-9A4A-506EDF61CFC6Q36194191-2A40859E-C54A-4902-A437-00F3DCF15DDCQ36656612-B8A61B99-02C0-4048-A16B-B00922267120Q36673829-1A14372C-71C3-439C-93AF-4F1068BBDFD5Q36728823-DF3911BC-464A-497A-83C4-89BCFAB8B9B7Q36865115-758D29EC-B004-4B2A-BFCE-A867725CFA08Q36874720-6AA07FE9-C16F-4A68-BDCC-AB790369DBCDQ37113543-700EE51C-3FD3-47ED-9AC7-43612A6C996DQ37122717-8DFFA451-120D-4F25-89BB-7D481D9AC76DQ37353089-41EC176E-0549-490D-95C1-5D119D862CA5Q37578521-48F2A1BA-769A-493A-AD48-87080951CF24Q37625817-BDD1F184-6BC1-46A5-8953-2F46EAD83390Q37689792-3247D098-B773-4263-B91F-2C3FEE104A9AQ37972813-0E83C315-F1C7-482D-986C-0ACD7877B94D
P2860
Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Hepatic arterial 90Yttrium gla ...... survival data on 65 patients.
@ast
Hepatic arterial 90Yttrium gla ...... survival data on 65 patients.
@en
type
label
Hepatic arterial 90Yttrium gla ...... survival data on 65 patients.
@ast
Hepatic arterial 90Yttrium gla ...... survival data on 65 patients.
@en
prefLabel
Hepatic arterial 90Yttrium gla ...... survival data on 65 patients.
@ast
Hepatic arterial 90Yttrium gla ...... survival data on 65 patients.
@en
P356
P1476
Hepatic arterial 90Yttrium gla ...... survival data on 65 patients.
@en
P2093
Brian I Carr
P304
P356
10.1002/LT.20036
P433
P577
2004-02-01T00:00:00Z